ATE277638T1 - Zubereitungen zur behandlung von gastrointestinalen störungen, welche arabinogalactan und polyphenole von larix enthalten. - Google Patents

Zubereitungen zur behandlung von gastrointestinalen störungen, welche arabinogalactan und polyphenole von larix enthalten.

Info

Publication number
ATE277638T1
ATE277638T1 AT95927341T AT95927341T ATE277638T1 AT E277638 T1 ATE277638 T1 AT E277638T1 AT 95927341 T AT95927341 T AT 95927341T AT 95927341 T AT95927341 T AT 95927341T AT E277638 T1 ATE277638 T1 AT E277638T1
Authority
AT
Austria
Prior art keywords
polyphenols
gastrointestinal tract
compositions
larix
preparations
Prior art date
Application number
AT95927341T
Other languages
English (en)
Inventor
Geoffrey N Richards
Original Assignee
Univ Montana
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Montana filed Critical Univ Montana
Application granted granted Critical
Publication of ATE277638T1 publication Critical patent/ATE277638T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT95927341T 1994-07-21 1995-07-21 Zubereitungen zur behandlung von gastrointestinalen störungen, welche arabinogalactan und polyphenole von larix enthalten. ATE277638T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27841494A 1994-07-21 1994-07-21
PCT/US1995/009230 WO1996003150A1 (en) 1994-07-21 1995-07-21 Compositions containing hemicelluloses and polyphenols for treating gastrointestinal disorders

Publications (1)

Publication Number Publication Date
ATE277638T1 true ATE277638T1 (de) 2004-10-15

Family

ID=23064883

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95927341T ATE277638T1 (de) 1994-07-21 1995-07-21 Zubereitungen zur behandlung von gastrointestinalen störungen, welche arabinogalactan und polyphenole von larix enthalten.

Country Status (5)

Country Link
US (2) US5614501A (de)
EP (1) EP0797451B1 (de)
AT (1) ATE277638T1 (de)
DE (1) DE69533593T2 (de)
WO (1) WO1996003150A1 (de)

Families Citing this family (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5614501A (en) * 1994-07-21 1997-03-25 The University Of Montana Compositions and methods for animal husbandry and for treating gastrointestinal disorders
AUPM835394A0 (en) * 1994-09-23 1994-10-13 King, Michael G. Dr. Method for controlling or eliminating the need to smoke tobacco, and for treating ailments which may lead to the said need
US6071480A (en) * 1994-12-22 2000-06-06 Abbott Laboratories Method for generating a standing sonic wave, methods of sonication with a standing sonic wave, and a standing sonic wave sonicator
ATE429212T1 (de) * 1995-12-26 2009-05-15 Cns Inc Verabreichungssystem für inulindiätfasern
US6297273B1 (en) 1996-04-02 2001-10-02 Mars, Inc. Use of cocoa solids having high cocoa polyphenol content in tabletting compositions and capsule filling compositions
US5965175A (en) * 1997-03-27 1999-10-12 The Iams Company Composition and method for repartitioning nitrogen and increasing colonic blood flow in dogs to promote intestinal health
FI107014B (fi) * 1997-07-25 2001-05-31 Oriola Oy Terveysravintovalmiste
WO1999015033A1 (en) * 1997-09-24 1999-04-01 Richards Geoffrey N Composition and method for reducing pathogenic bacteria in food products
US6039952A (en) 1997-10-22 2000-03-21 The Iams Company Composition and method for improving clinical signs in animals with renal disease
DK172775B1 (da) * 1998-03-12 1999-07-12 Diarex V G Andresen Dyrefoderadditiv med et indhold af et flavanoidholdigt mimosa-ekstrakt og dyrefoder indeholdende samme samt fremgangsmåde t
CA2330318A1 (en) 1998-04-27 1999-11-04 Larex, Inc. Derivatives of arabinogalactan and compositions including the same
WO2000064282A1 (en) * 1999-04-27 2000-11-02 Diomede Antonio Tortora Nutraceuticals and ingredients for functional foods
FR2801791B1 (fr) * 1999-12-03 2003-05-30 Elpronat Composition pour animaux contenant du salicylate de methyle
US6703056B2 (en) 2000-09-29 2004-03-09 The Procter + Gamble Co. Beverage compositions comprising arabinogalactan and defined minerals
US20020110632A1 (en) * 2000-09-29 2002-08-15 The Procter & Gamble Co. Beverage compositions comprising arabinogalactan and defined vitamins
US6706295B2 (en) 2000-09-29 2004-03-16 The Procter & Gamble Co. Compositions comprising arabinogalactan and a defined protein component
CA2440009C (en) * 2001-03-09 2011-05-10 Land O'lakes Farmland Feed Llc Method of feeding a ruminant
US6365152B1 (en) 2001-03-15 2002-04-02 Bovine Health Products, Inc. Scours treatment and method of making same
JP2004537325A (ja) 2001-08-20 2004-12-16 カー・イュー・ルーベン・リサーチ・アンド・ディベロップメント 非澱粉多糖類
AU2003266285A1 (en) * 2002-08-16 2004-03-11 Finzelberg Gmbh And Co. Kg Medicament, food supplement, and fodder additive
US7252836B2 (en) * 2003-01-13 2007-08-07 Penwest, Ltd. Food and feed compositions including resistant starch
US6936598B2 (en) * 2003-11-21 2005-08-30 Hill's Pet Nutrition, Inc. Composition and method
EP1695713A4 (de) * 2003-12-12 2009-06-24 Taiyo Kagaku Kk Zusammensetzung zur linderung von enteropathie
DE602004027120D1 (de) * 2004-05-25 2010-06-24 Cognis Ip Man Gmbh Orale und/oder topische Zubereitungen
BRPI0418986A (pt) * 2004-08-05 2007-12-11 Anidral Srl cepas bacterianas bifidobacterium produtoras de ácido fólico, formulações e seus usos
KR101530055B1 (ko) * 2005-10-11 2015-06-29 프로바이오티컬 에스.피.에이. 비알레르기성 프로바이오틱 박테리아 배양물의 제조 방법및 관련 용도
KR100710657B1 (ko) 2005-11-24 2007-04-24 코스맥스 주식회사 디하이드로퀘세틴을 함유하는 미백 화장료 조성물
EP2012596A1 (de) * 2006-05-03 2009-01-14 Anidral S.R.L. Symbiotische zusammensetzung, die unverdauliche polysaccharide und diese metabolisierende bifidobakterien enthält, und ihre verwendungen
US9420807B2 (en) * 2007-04-02 2016-08-23 Purina Animal Nutrition Llc Method of feeding young monogastric mammals and composition fed to young monogastric mammals
GB0718974D0 (en) 2007-09-28 2007-11-07 Univ Leuven Kath oligosaccharides derived from arabinoxylan for prevention of gastrointestinal infection
CA2747569A1 (en) * 2007-12-21 2009-07-02 University Of Graz Use larch wood material for treating inflammation
US8734867B2 (en) 2007-12-28 2014-05-27 Liveleaf, Inc. Antibacterial having an extract of pomegranate combined with hydrogen peroxide
EP2252601B1 (de) * 2008-01-24 2012-12-19 Vitae Pharmaceuticals, Inc. Cyclische carbazate und semicarbazide als inhibitoren von 11beta-hydroxysteroiddehydrogenase 1
GB0805360D0 (en) * 2008-03-25 2008-04-30 Univ Leuven Kath Arabinoxylan oligosaccharide preparation
EP2282648A4 (de) 2008-06-09 2011-09-21 Temple Inland Präbiotische zusammensetzungen sowie herstellungs- und verwendungsverfahren dafür
EP2403938B1 (de) 2009-03-04 2019-12-11 Liveleaf, Inc. Verfahren und material für stellenaktivierte komplexbildung biologischer moleküle
US8784844B2 (en) 2009-09-30 2014-07-22 Lonza Ltd. Arabinogalactan for enhancing the adaptive immune response
FI20096137A0 (fi) * 2009-11-04 2009-11-04 Upm Kymmene Corp Menetelmä eläimen ruoansulatuskanavan mikrobistoon vaikuttamiseksi, mikrobista modulaattoria sisältävä rehukoostumus ja mikrobisen modulaattorin käyttö
US9585920B2 (en) 2011-02-04 2017-03-07 Katherine Rose Kovarik Method and system for treating cancer cachexia
US9457077B2 (en) 2009-11-18 2016-10-04 Katherine Rose Kovarik Method and system for targeting the microbiome to promote health and treat allergic and inflammatory diseases
US9408880B2 (en) 2013-12-20 2016-08-09 Katherine Rose Kovarik Method and system for prevention and treatment of allergic and inflammatory diseases
EP2509453A4 (de) * 2009-12-08 2013-11-20 Tin Inc D B A Temple Inland Nährstoffzusammensetzung sowie verfahren zu ihrer herstellung und verwendung
US20110214318A1 (en) * 2010-03-05 2011-09-08 Sony Ericsson Mobile Communications Ab Paper Stock Card with Wireless Communication Capability
US10245288B2 (en) 2011-02-04 2019-04-02 Joseph E. Kovarik Method and system for reducing the likelihood of developing NASH in an individual diagnosed with non-alcoholic fatty liver disease
US10111913B2 (en) 2011-02-04 2018-10-30 Joseph E. Kovarik Method of reducing the likelihood of skin cancer in an individual human being
US12279989B2 (en) 2011-02-04 2025-04-22 Seed Health, Inc. Method and system for increasing beneficial bacteria and decreasing pathogenic bacteria in the oral cavity
US9987224B2 (en) 2011-02-04 2018-06-05 Joseph E. Kovarik Method and system for preventing migraine headaches, cluster headaches and dizziness
US9730967B2 (en) 2011-02-04 2017-08-15 Katherine Rose Kovarik Method and system for treating cancer cachexia
US11523934B2 (en) 2011-02-04 2022-12-13 Seed Health, Inc. Method and system to facilitate the growth of desired bacteria in a human's mouth
US10687975B2 (en) 2011-02-04 2020-06-23 Joseph E. Kovarik Method and system to facilitate the growth of desired bacteria in a human's mouth
US10835560B2 (en) 2013-12-20 2020-11-17 Joseph E. Kovarik Reducing the likelihood of skin cancer in an individual human being
US10086018B2 (en) 2011-02-04 2018-10-02 Joseph E. Kovarik Method and system for reducing the likelihood of colorectal cancer in a human being
US11419903B2 (en) 2015-11-30 2022-08-23 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US10010568B2 (en) 2011-02-04 2018-07-03 Katherine Rose Kovarik Method and system for reducing the likelihood of a spirochetes infection in a human being
US11844720B2 (en) 2011-02-04 2023-12-19 Seed Health, Inc. Method and system to reduce the likelihood of dental caries and halitosis
US12533312B2 (en) 2011-02-04 2026-01-27 Seed Health, Inc. Method and system for preventing sore throat in humans
US10583033B2 (en) 2011-02-04 2020-03-10 Katherine Rose Kovarik Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being
US12257272B2 (en) 2015-12-24 2025-03-25 Seed Health, Inc. Method and system for reducing the likelihood of developing depression in an individual
US11273187B2 (en) 2015-11-30 2022-03-15 Joseph E. Kovarik Method and system for reducing the likelihood of developing depression in an individual
US11951139B2 (en) 2015-11-30 2024-04-09 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US10512661B2 (en) 2011-02-04 2019-12-24 Joseph E. Kovarik Method and system for reducing the likelihood of developing liver cancer in an individual diagnosed with non-alcoholic fatty liver disease
US10548761B2 (en) 2011-02-04 2020-02-04 Joseph E. Kovarik Method and system for reducing the likelihood of colorectal cancer in a human being
US10842834B2 (en) 2016-01-06 2020-11-24 Joseph E. Kovarik Method and system for reducing the likelihood of developing liver cancer in an individual diagnosed with non-alcoholic fatty liver disease
US11357722B2 (en) 2011-02-04 2022-06-14 Seed Health, Inc. Method and system for preventing sore throat in humans
US11191665B2 (en) 2011-02-04 2021-12-07 Joseph E. Kovarik Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being
US10085938B2 (en) 2011-02-04 2018-10-02 Joseph E. Kovarik Method and system for preventing sore throat in humans
US11951140B2 (en) 2011-02-04 2024-04-09 Seed Health, Inc. Modulation of an individual's gut microbiome to address osteoporosis and bone disease
US10314865B2 (en) 2011-02-04 2019-06-11 Katherine Rose Kovarik Method and system for treating cancer and other age-related diseases by extending the healthspan of a human
US11998479B2 (en) 2011-02-04 2024-06-04 Seed Health, Inc. Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure
US9192635B2 (en) 2011-06-24 2015-11-24 Liveleaf, Inc. Method of treating damaged mucosal or gastrointestinal tissue by administering a composition comprising a mixture of pomegranate and green tea extracts and releasably bound hydrogen peroxide
US8722040B2 (en) 2011-06-24 2014-05-13 Liveleaf, Inc. Site-activated binding systems that selectively increase the bioactivity of phenolic compounds at target sites
US20130236529A1 (en) * 2012-03-09 2013-09-12 Flavitpure, Inc. Composition and methods to enhance anti-oxidation, gut flora and immunity in pets
EP2638914A1 (de) * 2012-03-16 2013-09-18 Lonza Ltd Zusammensetzung mit Arabinogalactan und Polyphenolen aus Lärchenbäumen
US8710027B2 (en) * 2012-04-10 2014-04-29 Flavitpure, Inc. Method of using nutritional compounds dihydroquercetin (taxifolin) and arabinogalactan in combination with dihydroquercetin (taxifolin) to reduce and control cardiometabolic risk factors associated with metabolic syndrome and hypercholesterolemia
US20130287919A1 (en) * 2012-04-26 2013-10-31 Flavitpure, Inc. Method of using dietary ingredients dihydroquercetin (taxifolin), arabinogalactan and arabinogalactan in combination with dihydroquercetin (taxifolin) for applications in food products
US20130331354A1 (en) * 2012-06-07 2013-12-12 Flavitpure, Inc. Method and composition utilizing larch wood extracts in animal feed
RU2504386C1 (ru) * 2012-12-18 2014-01-20 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Кубанский государственный аграрный университет" Препарат для профилактики диарей у новорожденных телят
US8716351B1 (en) 2012-12-23 2014-05-06 Liveleaf, Inc. Methods of treating gastrointestinal spasms
US9393259B2 (en) * 2013-03-21 2016-07-19 Lonza Ltd. Composition comprising arabinogalactan and polyphenols from larch trees
US10994013B2 (en) 2013-04-24 2021-05-04 Temple University—Of the Commonwealth System of Higher Education Solid dosage form containing arabinogalactan
US12005085B2 (en) 2013-12-20 2024-06-11 Seed Health, Inc. Probiotic method and composition for maintaining a healthy vaginal microbiome
US11826388B2 (en) 2013-12-20 2023-11-28 Seed Health, Inc. Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
US11998574B2 (en) 2013-12-20 2024-06-04 Seed Health, Inc. Method and system for modulating an individual's skin microbiome
US11833177B2 (en) 2013-12-20 2023-12-05 Seed Health, Inc. Probiotic to enhance an individual's skin microbiome
US11839632B2 (en) 2013-12-20 2023-12-12 Seed Health, Inc. Topical application of CRISPR-modified bacteria to treat acne vulgaris
US12246043B2 (en) 2013-12-20 2025-03-11 Seed Health, Inc. Topical application to treat acne vulgaris
US11980643B2 (en) 2013-12-20 2024-05-14 Seed Health, Inc. Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
US11969445B2 (en) 2013-12-20 2024-04-30 Seed Health, Inc. Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
US12329783B2 (en) 2013-12-20 2025-06-17 Seed Health, Inc. Method and system to improve the health of a person's skin microbiome
US12318377B2 (en) 2013-12-20 2025-06-03 Seed Health, Inc. Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being
US11547125B2 (en) 2015-02-13 2023-01-10 Mars, Incorporated Pet food feeding system
US20210038664A1 (en) * 2018-02-09 2021-02-11 Atp Institute Pty Ltd Formulation and method of use
US20210260142A1 (en) * 2020-02-26 2021-08-26 Ralco Nutrition, Inc. Compositions based on dietary fibers and essential oils

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3337526A (en) * 1965-10-15 1967-08-22 St Regis Paper Co Process for preparing arabinogalactan
SE446940B (sv) * 1983-02-16 1986-10-20 Carl Axel Virdalm Medel for bekempande av sjukdomstillstand i matsmeltningsapparaten innehallande skal eller ytterdelar av ber eller frukter
SE8304821L (sv) * 1983-09-08 1985-03-09 Bio Carb Ab Arabinogalaktaner, deras framstellning och kompositioner innehallande desamma
DK454683D0 (da) * 1983-10-03 1983-10-03 Mogens Gjerloev Tarmreguleringsmiddel til behandling af diarre hos dyr samt anvendelse heraf
DE3564370D1 (en) * 1985-08-30 1988-09-22 Nestle Sa Dietetic product with depurating and antidiarrheal activity and process for its preparation
DE3622896A1 (de) * 1986-07-08 1988-01-21 Klaus Dr Laemmerhirt Verbindung von tannin und vernetztem polyvinylpyrrolidon zur behandlung von durchfallerkrankungen und wunden
US4927811A (en) * 1988-11-15 1990-05-22 Coors Biotech, Inc. Method and composition for improved animal husbandry
GB8923890D0 (en) * 1989-10-24 1989-12-13 Rowett Research Services Limit Dietary material
US5294458A (en) * 1992-04-03 1994-03-15 Maruha Corporation Pet food
JPH06219953A (ja) * 1993-01-27 1994-08-09 Ajinomoto Co Inc 下痢予防改善剤、下痢予防改善食品および下痢予防改善飼料
US5439893A (en) * 1993-05-26 1995-08-08 University Of Montana Methods for the treatment and prevention of diarrhea
US5614501A (en) * 1994-07-21 1997-03-25 The University Of Montana Compositions and methods for animal husbandry and for treating gastrointestinal disorders
US5882520A (en) * 1995-10-26 1999-03-16 The University Of Montana Use of arabinogalactan in aqueous two phase extractions

Also Published As

Publication number Publication date
WO1996003150A1 (en) 1996-02-08
EP0797451B1 (de) 2004-09-29
US5614501A (en) 1997-03-25
EP0797451A2 (de) 1997-10-01
DE69533593D1 (de) 2004-11-04
US6087092A (en) 2000-07-11
DE69533593T2 (de) 2005-10-13

Similar Documents

Publication Publication Date Title
DE69533593D1 (de) Zubereitungen zur behandlung von gastrointestinalen störungen, welche arabinogalactan und polyphenole von larix enthalten.
US4314995A (en) Pharmaceutical lactobacillus preparations
WO1996003150B1 (en) Compositions containing hemicelluloses and polyphenols for treating gastrointestinal disorders
DE3684409D1 (de) Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eubnes arzneimittels zur behandlung von endometriose.
NZ544801A (en) Antiseptic compositions, methods and systems
GR1002451B (el) Αντιφλεγμονωδεις συνθεσεις που εχουν ως βαση ενεργα συστατικα ορισμενων βοτανων χρησιμοποιουμενες για σκοπους ιατρικους και κτηνιατρικους, και μεθοδοι παρασκευης φαρμακων και σκευασματων για τους παραπανω σκοπους.
FI971951A0 (fi) 2,2-dikloroalkaanikarboksyylihapot, menetelmät niiden valmistamiseksi, niitä sisältävät lääkkeet, ja niiden käyttö insuliiniresistanssin hoitoon
ATE336997T1 (de) Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen
GR3036774T3 (en) Compositions containing G-CSF and TNF binding protein.
ATE172117T1 (de) Verwendung von trospiumchlorid zur herstellung eines arzneimittels zur behandlung von blasenkrankheiten
JP2832517B2 (ja) 大腸菌付着阻止剤
MX9701187A (es) Nuevas lactamas naftofusionadas n-substituidas.
ATE201598T1 (de) Verwendung von moxonidin zur behandlung neuropathischer schmerzen
EE03373B1 (et) Taimeseemnete kvaliteedi parandamise meetod
DE69002024T2 (de) Bioaktive Laktoferrin Derivate.
NZ510153A (en) Tan-1057 derivatives with reduced toxicity and their use in medicaments for treating bacterial infections in humans and mammals
DE60026883D1 (de) Methoden und zusammensetzungen zur behandlung von schmerzen
DE69929616D1 (de) Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen
DE2738652A1 (de) Lactobacillus-praeparat und seine verwendung zur behandlung bakterieller infektionen
ATE321553T1 (de) Arzneimittel für hinterstrangataxie und zusammensetzung zur behandlung von hinterstrangataxie
US7465576B2 (en) Method for treating periodontal disease with a bacteriocidal disinfectant
EP1676583A2 (de) Therapeutisches mittel für periodont-erkrankungen
Kielstein Systematic control of dermatophytosis profunda of cattle in the former GDR
RU2097030C1 (ru) Препарат для аэрозольного использования против респираторных заболеваний животных и птиц
DE69941459D1 (de) Verfahren zur herstellung von essbaren zusammenstellungen mit antibakteriellen wirkstoffen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties